CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase

Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim

Clin Mol Hepatol. 2023;29(2):482-495. Published online 2023 January 5 DOI: https://doi.org/10.3350/cmh.2022.0322

Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”

Chia-Ming Chu, Yun-Fan Liaw

Clinical and Molecular Hepatology. 2023;29(2):510-512

Link1

Link2 Link3

Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”

Jeong-Ju Yoo, Sang Gyune Kim

Clinical and Molecular Hepatology. 2023;29(2):513-515

Link1

Link2 Link3

Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase

Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim

Clinical and Molecular Hepatology. 2023;29(2):482-495

Link1

Link2 Link3

Clinical, serological and histologic follow-up of chronic HBV and HDV hepatitis

Journal of Hepatology. 1987;5:S136

Link1 Link2

Long-term histologic outcome of chronic posttransfusion NANB hepatitis evaluated by a scoring system

L Mattsson, O Weiland, H Ghumann

Journal of Hepatology. 1990;11:S161

Link1 Link2

Change of the host immune response during the early phase of interferon therapy correlates with its long-term efficacy for chronic hepatitis C

Y Momosaka

Hepatology Research. 2001;19(2):131-143

Link1 Link2

Potential treatment for chronic hepatitis B carriers at immune tolerant phase

R Guo

Focus on Alternative and Complementary Therapies. 2014;19(2):96-97

Link1 Link2

Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study

F Imazeki

Hepatology. 2003;38(2):493-502

Link1 Link2

Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B

Mayur Gattani, Meghraj Ingle, Shamshersingh Chauhan, Saiprasad Lad

Alimentary Pharmacology & Therapeutics. 2020;52(5):911-912

Link1 Link2

Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors’ reply

Han Ah Lee, Seung Up Kim

Alimentary Pharmacology & Therapeutics. 2020;52(5):913-914

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.